Improving Medication Adherence
One Patient At A Time
30% of medication prescriptions never get filled.
50% of patients fail to take their medications as prescribed.
The result: poor outcomes and $105 - $300 billion in wasted healthcare spending.
Improving medication adherence drives value for all
- Physicians & clinicians: Our clinical pharmacists and patient care coordinators provide medication education, mitigate side effects, reconcile regimens and keep patients on track. As reimbursement shifts to outcomes dependence, we are your value-based partner in improving patient outcomes.
- For payers & PBMs: Improving medication adherence, especially for the most difficult and costly patients to treat, means lower overall healthcare costs.
- For manufacturers: We bridge the gaps in current care models and increase brand sustainability. We: 1) maximize patient access to therapy 2) provide continuous patient and provider engagement and 3) deliver consistent reporting of key clinical performance metrics.
- For patients: Medication adherence starts with access and continues with education so you can stay on track. At every step we are committed to helping improve outcomes and lives.
Proof Curant Improves Adherence
- For a cohort of hepatitis C and HIV co-infected patients, Curant’s C The Cure program produces sustained virological response (SVR12) in 89.7% of program patients at 12 weeks post treatment. Read more.
- For a cohort of HIV patients on highly active antiretroviral therapy, after six months of pharmacy care, mean medication adherence increased 28% and mean CD4 cell count increased 38%. The number of patients achieving greater than 95% adherence increased 69%. Furthermore, the improved outcomes has been associated with overall healthcare cost savings of about $3,000 per member per year. Read more.
- In a study presented during the 10th International Conference on HIV Treatment and Prevention Adherence, out of 157 HIV patients whose viral loads were not suppressed prior to enrollment in Curant Health’s medication management protocols, 103 have now achieved viral suppression.
Improving adherence requires evaluation of the whole patient
We place the patient at the center of every conversation. We look beyond the disease or the symptoms to uncover other barriers to medication adherence and improved health outcomes.
Other medications? Side effect implications and mitigation? Lifestyle and level of education? Barriers to adherence like cost, access to care or need for further education?
Regardless of your role in the continuum of care, poor medication adherence is a massive impediment to improving value. If you are interested in improving health outcomes and reducing costs through improved medication adherence, especially for the most difficult to treat, chronically ill patients, let’s talk.